Viral Clearance Validation Study Protocol Inspection
Use this Viral Clearance Validation Study Protocol Inspection template to verify the study plan, virus panel, sampling, LRV calculations, and deviation handling before execution. It helps quality teams catch protocol gaps that could undermine a viral clearance claim.
Trusted by frontline teams 15 years of frontline software AI customization in seconds
Built for: Biopharmaceutical Manufacturing · Biologics Quality Assurance · Contract Development And Manufacturing Organizations · Cell And Gene Therapy · Vaccine Manufacturing
Overview
This inspection template is for reviewing a viral clearance validation study protocol before the study is executed. It focuses on the items that determine whether the study can support a credible viral safety claim: protocol control, the virus panel and spiking strategy, the purification steps being challenged, sampling and assay controls, LRV calculation rules, and how deviations will be handled.
Use it when a process includes one or more viral clearance unit operations such as low-pH hold, solvent/detergent treatment, nanofiltration, chromatography, or other removal or inactivation steps that must be justified in a regulated quality package. It is especially useful when the process has changed, the scale has changed, the assay has been updated, or the team needs to confirm that orthogonal clearance claims are supported by the protocol language.
Do not use this template as a substitute for the actual validation study report, and do not use it for unrelated environmental or facility inspections. It is not a general GMP checklist. It is also not appropriate when the process has no viral safety claim to validate or when the study design is still too early to define challenged steps, virus selection, or assay strategy. The goal is to catch protocol-level deficiencies before they become unfixable study limitations, missing controls, or non-defensible LRV calculations.
Standards & compliance context
- The template supports the type of documented, risk-based viral safety evaluation expected in ICH Q5A(R2) programs for biologics.
- Its structure aligns with quality system expectations for controlled protocols, approved deviations, and traceable records under GMP principles.
- Clear separation of removal and inactivation claims helps support defensible validation narratives during regulatory review.
- Assay qualification, matrix interference checks, and documented detection limits reflect common expectations in validated analytical practice.
General regulatory context for orientation only — verify current requirements with counsel or the relevant agency before relying on this template for compliance.
What's inside this template
Study Scope and Protocol Control
This section matters because it anchors the inspection to the exact protocol, product, process, and approvals being reviewed.
- Protocol title, version, and effective date are documented
- Study objective clearly states viral clearance validation across defined purification steps
- Product, process, and manufacturing scale are identified
- Referenced governing documents include ICH Q5A(R2) and applicable internal SOPs
- Study roles and approvals are assigned to qualified personnel
Virus Panel and Spiking Strategy
This section matters because the virus selection and challenge design determine whether the study can actually test the clearance claim.
- Virus panel includes relevant model viruses representing different physicochemical properties
- Virus stock identity, passage history, and titer are documented
- Spiking point and target spike ratio are defined for each challenged unit operation
- Spike recovery and hold-time controls are included where applicable
- Virus handling and containment controls are defined for the study
Purification Steps and Orthogonal Clearance Claims
This section matters because each step must be challenged in process order with a clear, non-overlapping clearance rationale.
- Each purification step evaluated for viral clearance is listed in process order
- Orthogonal clearance mechanisms are identified across steps
- Worst-case operating conditions are justified for each challenged step
- Process parameters affecting clearance are specified with acceptable ranges
- Inactivation and removal claims are not conflated in the protocol
Sampling, Assay Controls, and Analytical Method
This section matters because sample handling and assay suitability determine whether the measured clearance result is trustworthy.
- Pre- and post-step sample points are defined for each clearance unit operation
- Sample volumes, dilution scheme, and storage conditions are specified
- Assay method is qualified or validated for the intended matrix
- Assay controls include positive control, negative control, and matrix interference assessment
- Limit of detection and limit of quantitation are documented for the assay
Log-Reduction Calculations and Data Integrity
This section matters because the LRV math and traceability must be consistent, reproducible, and audit-ready.
- LRV calculation method is defined for each step and for cumulative clearance
- Treatment of values below the assay detection limit is defined
- Replicate handling and averaging rules are specified
- Raw data, calculations, and audit trail are retained and traceable
Deviations, Acceptance Criteria, and Final Report
This section matters because predefined acceptance rules and documented deviation review determine whether the study conclusion is defensible.
- Acceptance criteria for each clearance step and cumulative LRV are predefined
- Protocol deviations and out-of-trend results require documented assessment
- Final report includes conclusion on viral clearance adequacy and study limitations
- Final report is reviewed and approved by authorized quality and technical signatories
How to use this template
- 1. Confirm the protocol title, version, effective date, product, process, scale, and governing documents so the inspection is tied to the exact study being reviewed.
- 2. Verify that the virus panel, stock identity, passage history, titer, spike point, and target spike ratio are defined for each challenged unit operation.
- 3. Walk through the purification steps in process order and confirm that each claimed clearance mechanism, worst-case condition, and operating range is explicitly stated.
- 4. Check that sampling points, sample handling, assay qualification or validation status, controls, and detection limits are defined for the intended matrix.
- 5. Review the LRV calculation method, below-detection handling, replicate rules, and data traceability, then document any deviations, acceptance gaps, or required protocol revisions.
Best practices
- Keep inactivation and removal claims separate in the protocol so the clearance mechanism for each step is unambiguous.
- Use a virus panel that reflects different physicochemical properties, not just the easiest model virus to clear.
- Document the exact spike point and target spike ratio for every challenged unit operation so the study can be reproduced.
- Define worst-case operating conditions with a clear rationale, especially for pH, contact time, load, flow, and hold-time limits.
- Require the assay package to state the matrix, controls, and detection limits before the study starts, not after results are generated.
- State how results below the detection limit will be treated in the LRV calculation so the math is consistent across steps and replicates.
- Photograph or otherwise capture raw records and calculations at the time of review so the audit trail stays traceable to source data.
What this template typically catches
Issues teams running this template most often surface in practice:
Common use cases
Frequently asked questions
What does this inspection template cover?
It is built to review a viral clearance validation study protocol before the study starts, not to audit the final report only. The template checks protocol control, virus selection, spiking strategy, purification steps, assay controls, LRV calculations, and deviation handling. It is meant to confirm the study can support a defensible viral clearance claim for the defined process and scale.
When should this inspection be used?
Use it during protocol drafting, quality review, and pre-execution approval for a new or changed purification process. It is also useful after a protocol revision, a scale change, a new virus panel, or a method update that could affect clearance results. If the study is already complete, this template can still be used as a gap review, but it is most valuable before the run.
Who should run this inspection?
A qualified quality reviewer, validation lead, or technical reviewer should run it, with input from virology, downstream process development, and analytical method owners. The reviewer should understand orthogonal clearance claims, assay limitations, and how the process is challenged at worst-case conditions. Final approval typically belongs to designated quality and technical signatories.
Does this template align with regulatory expectations?
Yes, it is framed around the expectations commonly associated with ICH Q5A(R2) for viral safety evaluation of biotechnology products. It also supports good documentation practices expected in regulated quality systems, including traceable raw data, predefined acceptance criteria, and documented deviation assessment. Depending on the facility and product, internal SOPs and other quality system requirements may also apply.
What are the most common mistakes this inspection catches?
Common issues include an incomplete virus panel, unclear spiking ratios, missing justification for worst-case conditions, and protocol language that mixes inactivation with removal claims. Reviewers also often find weak assay control documentation, undefined handling for results below the detection limit, and LRV calculations that are not fully traceable. These gaps can make the study hard to defend even if the run itself looks successful.
How often should a viral clearance protocol be inspected?
Inspect every protocol before execution and again whenever the study design changes in a way that could affect the clearance claim. That includes changes to the purification train, process parameters, scale, assay method, or virus panel. For ongoing programs, many teams also use the template as part of periodic quality review of validation packages.
Can this template be customized for different products or platforms?
Yes, and it should be. The sections are designed to be adapted for monoclonal antibodies, recombinant proteins, plasma-derived products, or other biologics with different purification steps and risk profiles. You can tailor the virus panel, challenge points, assay controls, and acceptance criteria to the product, process, and manufacturing scale being studied.
How does this compare with an ad hoc protocol review?
An ad hoc review often misses traceability between the protocol objective, the challenged steps, and the final LRV claim. This template forces a structured walk-through of the study from scope to final report, which makes it easier to spot missing controls, ambiguous wording, and unsupported assumptions. It also creates a repeatable review record that is easier to defend during quality or regulatory review.
Related templates
Go deeper on the topic
-
A daily huddle is a brief (10–15 minute) standing meeting held at the start of a shift or workday to align the team on priorities, surface issues, and...
-
A deskless worker is any employee whose job happens without a desk, a company laptop, or a fixed workstation. They're roughly 80% of the global workforce —...
-
A frontline employee app is a phone-first application that gives hourly, field, and deskless workers access to their schedule, pay, announcements, training,...
-
A frontline worker is any employee whose job happens away from a desk — on a production floor, in a patient room, behind a store counter, in a customer's...
-
Discover 4 proven keys to successful project management and team collaboration — from transparent goal-setting to real-time communication and workflow...
-
Boost team collaboration with modern tools that improve visibility, accountability, and communication for stronger project outcomes.
-
Compare the best employee apps of 2026—MangoApps, Blink, WorkJam, Flip, and more—to find the right fit for your frontline workforce.
-
Discover why an employee text alert system is essential for frontline safety, faster emergency response, and two-way communication across your entire workforce.
Ready to use this template?
Get started with MangoApps and use Viral Clearance Validation Study Protocol Inspection with your team — pricing built for small business.
